Deep Brain Stimulation Devices Market

Deep brain stimulation (DBS) is a neurosurgical procedure involving the implantation of a medical device called a neurostimulator (sometimes referred to as a 'brain pacemaker'), which sends electrical impulses, through implanted electrodes, to specific targets in the brain (brain nuclei) for the treatment of movement and neuropsychiatric disorders. DBS in select brain regions has provided therapeutic benefits for otherwise-treatment-resistant disorders such as Parkinson's disease, essential tremor, dystonia, chronic pain, major depression and obsessive?compulsive disorder (OCD). Despite the long history of DBS, its underlying principles and mechanisms are still not clear. DBS directly changes brain activity in a controlled manner, its effects are reversible (unlike those of lesioning techniques), and it is one of only a few neurosurgical methods that allow blinded studies.

Deep Brain Stimulation Devices Market contains market size and forecasts of Deep Brain Stimulation Devices in global, including the following market information:

Global Deep Brain Stimulation Devices Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Deep Brain Stimulation Devices Market Sales, 2017-2022, 2023-2028, (Units)

Global top five Deep Brain Stimulation Devices companies in 2021 (%)

The global Deep Brain Stimulation Devices market was valued at 1131.8 million in 2021 and is projected to reach US$ 2212.5 million by 2028, at a CAGR of 10.0% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Single-channel DBS Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Deep Brain Stimulation Devices include Medtronic, Boston Scientific, Abbott, Beijing Pins and SceneRay, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Deep Brain Stimulation Devices manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Deep Brain Stimulation Devices Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Units)

Global Deep Brain Stimulation Devices Market Segment Percentages, by Type, 2021 (%)

Single-channel DBS

Dual Channel DBS

Global Deep Brain Stimulation Devices Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Units)

Global Deep Brain Stimulation Devices Market Segment Percentages, by Application, 2021 (%)

Parkinson's Disease

Essential Tremor

Dystonia

Others

Global Deep Brain Stimulation Devices Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Units)

Global Deep Brain Stimulation Devices Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Deep Brain Stimulation Devices revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Deep Brain Stimulation Devices revenues share in global market, 2021 (%)

Key companies Deep Brain Stimulation Devices sales in global market, 2017-2022 (Estimated), (Units)

Key companies Deep Brain Stimulation Devices sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Medtronic

Boston Scientific

Abbott

Beijing Pins

SceneRay